Hexagon Capital Partners’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-96
Closed -$2.84K 786
2025
Q1
$2.84K Buy
96
+16
+20% +$594 ﹤0.01% 1313
2024
Q4
$1.93K Sell
80
-144
-64% -$3.57K ﹤0.01% 1423
2024
Q3
$4.13K Sell
224
-276
-55% -$4.94K ﹤0.01% 1096
2024
Q2
$10.1K Buy
500
+438
+706% +$7.29K ﹤0.01% 875
2024
Q1
$959 Buy
+62
New +$699 ﹤0.01% 1278

Other funds holding HIMS

Hexagon Capital Partners's HIMS Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Hims & Hers Health (HIMS) in Q2 2025, closing a stake of 96 shares — an estimated $2.84K sold.

Hexagon Capital Partners first reported a position in HIMS in Q1 2024 and held it in 5 quarters. The position peaked at $10.1K in Q2 2024. 510 funds tracked by Wall St. Rank hold HIMS as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Hims & Hers Health position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 96 Hims & Hers Health shares in Q2 2025, an estimated $2.84K.
  • Hexagon Capital Partners first reported a position in Hims & Hers Health in Q1 2024 and held it in 5 quarters.
  • Hexagon Capital Partners's Hims & Hers Health position peaked at $10.1K in Q2 2024.
  • 510 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.